BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

710 related articles for article (PubMed ID: 30240292)

  • 1. Contrast-Enhanced Spectral Mammography in Women With Intermediate Breast Cancer Risk and Dense Breasts.
    Sorin V; Yagil Y; Yosepovich A; Shalmon A; Gotlieb M; Neiman OH; Sklair-Levy M
    AJR Am J Roentgenol; 2018 Nov; 211(5):W267-W274. PubMed ID: 30240292
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic accuracy of contrast-enhanced spectral mammography in comparison to conventional full-field digital mammography in a population of women with dense breasts.
    Mori M; Akashi-Tanaka S; Suzuki S; Daniels MI; Watanabe C; Hirose M; Nakamura S
    Breast Cancer; 2017 Jan; 24(1):104-110. PubMed ID: 26942415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contrast-Enhanced Spectral Mammography Versus Ultrasonography: Diagnostic Performance in Symptomatic Patients with Dense Breasts.
    Lu Z; Hao C; Pan Y; Mao N; Wang X; Yin X
    Korean J Radiol; 2020 Apr; 21(4):442-449. PubMed ID: 32193892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [CONTRAST ENHANCED SPECTRAL MAMMOGRAPHY IN WOMEN WITH INTERMEDIATE BREAST CANCER RISK AND DENSE BREAST].
    Sklair-Levy M; Sorin V; Yagil Y; Shalmon A; Halshtok Neiman O; Samoocha D; Faermann Weidenfeld R
    Harefuah; 2022 Feb; 161(2):89-94. PubMed ID: 35195969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contrast-enhanced spectral mammography vs. mammography and MRI - clinical performance in a multi-reader evaluation.
    Fallenberg EM; Schmitzberger FF; Amer H; Ingold-Heppner B; Balleyguier C; Diekmann F; Engelken F; Mann RM; Renz DM; Bick U; Hamm B; Dromain C
    Eur Radiol; 2017 Jul; 27(7):2752-2764. PubMed ID: 27896471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Added Value of Contrast-Enhanced Spectral Mammography in Postscreening Assessment.
    Tardivel AM; Balleyguier C; Dunant A; Delaloge S; Mazouni C; Mathieu MC; Dromain C
    Breast J; 2016 Sep; 22(5):520-8. PubMed ID: 27345656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contrast-enhanced spectral mammography (CESM) in women presenting with palpable breast findings.
    Sorin V; Faermann R; Yagil Y; Shalmon A; Gotlieb M; Halshtok-Neiman O; Ben-David MA; Sklair-Levy M
    Clin Imaging; 2020 May; 61():99-105. PubMed ID: 32014818
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contrast-enhanced spectral mammography (CESM) versus breast magnetic resonance imaging (MRI): A retrospective comparison in 66 breast lesions.
    Li L; Roth R; Germaine P; Ren S; Lee M; Hunter K; Tinney E; Liao L
    Diagn Interv Imaging; 2017 Feb; 98(2):113-123. PubMed ID: 27687829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the Mammography, Contrast-Enhanced Spectral Mammography and Ultrasonography in a Group of 116 patients.
    Luczyńska E; Heinze S; Adamczyk A; Rys J; Mitus JW; Hendrick E
    Anticancer Res; 2016 Aug; 36(8):4359-66. PubMed ID: 27466557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison between breast MRI and contrast-enhanced spectral mammography.
    Łuczyńska E; Heinze-Paluchowska S; Hendrick E; Dyczek S; Ryś J; Herman K; Blecharz P; Jakubowicz J
    Med Sci Monit; 2015 May; 21():1358-67. PubMed ID: 25963880
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic Value of Contrast-Enhanced Spectral Mammography in Comparison to Magnetic Resonance Imaging in Breast Lesions.
    Xing D; Lv Y; Sun B; Xie H; Dong J; Hao C; Chen Q; Chi X
    J Comput Assist Tomogr; 2019; 43(2):245-251. PubMed ID: 30531546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contrast-enhanced spectral mammography: A potential exclusion diagnosis modality in dense breast patients.
    Qin Y; Liu Y; Zhang X; Zhao S; Zhong H; Huang J; Yu J
    Cancer Med; 2020 Apr; 9(8):2653-2659. PubMed ID: 32074407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A prospective comparative trial of adjunct screening with tomosynthesis or ultrasound in women with mammography-negative dense breasts (ASTOUND-2).
    Tagliafico AS; Mariscotti G; Valdora F; Durando M; Nori J; La Forgia D; Rosenberg I; Caumo F; Gandolfo N; Sormani MP; Signori A; Calabrese M; Houssami N
    Eur J Cancer; 2018 Nov; 104():39-46. PubMed ID: 30316869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contrast-enhanced spectral mammography in recalls from the Dutch breast cancer screening program: validation of results in a large multireader, multicase study.
    Lalji UC; Houben IP; Prevos R; Gommers S; van Goethem M; Vanwetswinkel S; Pijnappel R; Steeman R; Frotscher C; Mok W; Nelemans P; Smidt ML; Beets-Tan RG; Wildberger JE; Lobbes MB
    Eur Radiol; 2016 Dec; 26(12):4371-4379. PubMed ID: 27097789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does three-dimensional functional infrared imaging improve breast cancer detection based on digital mammography in women with dense breasts?
    Hellgren RJ; Sundbom AE; Czene K; Izhaky D; Hall P; Dickman PW
    Eur Radiol; 2019 Nov; 29(11):6227-6235. PubMed ID: 31115623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contrast-enhanced spectral mammography as work-up tool in patients recalled from breast cancer screening has low risks and might hold clinical benefits.
    Houben IPL; Van de Voorde P; Jeukens CRLPN; Wildberger JE; Kooreman LF; Smidt ML; Lobbes MBI
    Eur J Radiol; 2017 Sep; 94():31-37. PubMed ID: 28941757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contrast-enhanced spectral mammography in patients referred from the breast cancer screening programme.
    Lobbes MB; Lalji U; Houwers J; Nijssen EC; Nelemans PJ; van Roozendaal L; Smidt ML; Heuts E; Wildberger JE
    Eur Radiol; 2014 Jul; 24(7):1668-76. PubMed ID: 24696228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Performance of Dual-Energy Contrast-enhanced Digital Mammography for Screening Women at Increased Risk of Breast Cancer.
    Sung JS; Lebron L; Keating D; D'Alessio D; Comstock CE; Lee CH; Pike MC; Ayhan M; Moskowitz CS; Morris EA; Jochelson MS
    Radiology; 2019 Oct; 293(1):81-88. PubMed ID: 31453765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Performance of DWI as a Rapid Unenhanced Technique for Detecting Mammographically Occult Breast Cancer in Elevated-Risk Women With Dense Breasts.
    McDonald ES; Hammersley JA; Chou SH; Rahbar H; Scheel JR; Lee CI; Liu CL; Lehman CD; Partridge SC
    AJR Am J Roentgenol; 2016 Jul; 207(1):205-16. PubMed ID: 27077731
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 36.